Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Hendrix

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Vaccine|January 1, 1993
Estimates of human immunodeficiency virus (HIV) incidence and trends in the US Air ForceR D Warner, R E Mathis, M E Weston, et al.
Vaccine|January 1, 1993
Early markers of HIV infection and subclinical disease progressionM J Dolan, D R Lucey, C W Hendrix, et al.
The Journal of Clinical Investigation|March 1, 1993
Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individualsM Clerici, F T Hakim, D J Venzon, et al.
The Journal of Infectious Diseases|August 1, 1997
Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patientsP Barditch-Crovo, J Toole, C W Hendrix, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteersC W Hendrix, C Flexner, R T MacFarland, et al.
Annals of Surgery|April 17, 2001
Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patientsR K Pelz, C W Hendrix, S M Swoboda, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 11, 1999
Escalating multiple-dose safety and tolerance study of oral WR 6026 in HIV-infected subjects: AIDS clinical trials group 173B G Petty, J R Black, C W Hendrix, et al.
Lancet (London, England)|August 26, 1989
Probenecid and zidovudine metabolismD M Kornhauser, B G Petty, C W Hendrix, et al.
Clinical Pharmacology and Therapeutics|May 1, 1999
The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptiveP Barditch-Crovo, C B Trapnell, E Ette, et al.
The Journal of Clinical Investigation|February 1, 1994
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virusM Clerici, T A Wynn, J A Berzofsky, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Vaccine|January 1, 1993
Estimates of human immunodeficiency virus (HIV) incidence and trends in the US Air ForceR D Warner, R E Mathis, M E Weston, et al.
Vaccine|January 1, 1993
Early markers of HIV infection and subclinical disease progressionM J Dolan, D R Lucey, C W Hendrix, et al.
The Journal of Clinical Investigation|March 1, 1993
Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individualsM Clerici, F T Hakim, D J Venzon, et al.
The Journal of Infectious Diseases|August 1, 1997
Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patientsP Barditch-Crovo, J Toole, C W Hendrix, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteersC W Hendrix, C Flexner, R T MacFarland, et al.
Annals of Surgery|April 17, 2001
Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patientsR K Pelz, C W Hendrix, S M Swoboda, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 11, 1999
Escalating multiple-dose safety and tolerance study of oral WR 6026 in HIV-infected subjects: AIDS clinical trials group 173B G Petty, J R Black, C W Hendrix, et al.
Lancet (London, England)|August 26, 1989
Probenecid and zidovudine metabolismD M Kornhauser, B G Petty, C W Hendrix, et al.
Clinical Pharmacology and Therapeutics|May 1, 1999
The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptiveP Barditch-Crovo, C B Trapnell, E Ette, et al.
The Journal of Clinical Investigation|February 1, 1994
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virusM Clerici, T A Wynn, J A Berzofsky, et al.
Pageof 6